Advanced

MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review

Catto, James W. F.; Alcaraz, Antonio; Bjartell, Anders LU ; White, Ralph De Vere; Evans, Christopher P.; Fussel, Susanne; Hamdy, Freddie C.; Kallioniemi, Olli; Mengual, Lourdes and Schlomm, Thorsten, et al. (2011) In European Urology 59(5). p.671-681
Abstract
Context: MicroRNAs (miRNA) are noncoding RNAs that post- transcriptionally regulate gene expression. Their altered expression and function have been observed in most urologic cancers. MiRNAs represent potential disease biomarkers and novel therapeutic targets. Objective: To review and evaluate the evidence implicating miRNAs in the pathogenesis of prostate cancer (PCa), bladder cancer (BCa), and renal cancer. Evidence acquisition: A systematic review was performed using PubMed and Embase to search for reports using strings for microRNA, non- coding RNA, cancer, prostate, bladder, and renal cancer. Identified manuscripts were retrieved and references searched. Selected studies were required to concentrate on the role of miRNA in these... (More)
Context: MicroRNAs (miRNA) are noncoding RNAs that post- transcriptionally regulate gene expression. Their altered expression and function have been observed in most urologic cancers. MiRNAs represent potential disease biomarkers and novel therapeutic targets. Objective: To review and evaluate the evidence implicating miRNAs in the pathogenesis of prostate cancer (PCa), bladder cancer (BCa), and renal cancer. Evidence acquisition: A systematic review was performed using PubMed and Embase to search for reports using strings for microRNA, non- coding RNA, cancer, prostate, bladder, and renal cancer. Identified manuscripts were retrieved and references searched. Selected studies were required to concentrate on the role of miRNA in these urologic cancers. Evidence synthesis: We reviewed articles that focus on this topic. More than 40 miRNAs have been implicated in urologic cancer and many target common carcinogenic pathways. In particular, apoptosis avoidance, cell proliferation, epithelial- to- mesenchymal transition, angiogenic signalling, and the generation of androgen independence are targeted or facilitated by more than one miRNA. Little work has been done to evaluate the translational applications for this knowledge to date. Novel therapeutic strategies have been developed and are under investigation to selectively modulate miRNAs; such work would potentially enable personalised tumour therapy. Conclusions: MiRNAs appear to be important modulators of urologic cancer. Their expression is frequently altered in these tumours, and many are functionally implicated in their pathogenesis. They require evaluation to determine the translational role and therapeutic potential for this knowledge. Crown Copyright (C) 2011 Published by Elsevier B. V. on behalf of European Association of Urology. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
MicroRNA, Gene regulation, Prostate, Bladder, Kidney, Cancer
in
European Urology
volume
59
issue
5
pages
671 - 681
publisher
Elsevier
external identifiers
  • wos:000288991500005
  • scopus:79953249325
ISSN
1873-7560
DOI
10.1016/j.eururo.2011.01.044
language
English
LU publication?
yes
id
b566344d-30b6-4eda-8cad-ff9d229809d6 (old id 1918600)
date added to LUP
2011-05-02 11:00:44
date last changed
2017-11-12 03:45:54
@article{b566344d-30b6-4eda-8cad-ff9d229809d6,
  abstract     = {Context: MicroRNAs (miRNA) are noncoding RNAs that post- transcriptionally regulate gene expression. Their altered expression and function have been observed in most urologic cancers. MiRNAs represent potential disease biomarkers and novel therapeutic targets. Objective: To review and evaluate the evidence implicating miRNAs in the pathogenesis of prostate cancer (PCa), bladder cancer (BCa), and renal cancer. Evidence acquisition: A systematic review was performed using PubMed and Embase to search for reports using strings for microRNA, non- coding RNA, cancer, prostate, bladder, and renal cancer. Identified manuscripts were retrieved and references searched. Selected studies were required to concentrate on the role of miRNA in these urologic cancers. Evidence synthesis: We reviewed articles that focus on this topic. More than 40 miRNAs have been implicated in urologic cancer and many target common carcinogenic pathways. In particular, apoptosis avoidance, cell proliferation, epithelial- to- mesenchymal transition, angiogenic signalling, and the generation of androgen independence are targeted or facilitated by more than one miRNA. Little work has been done to evaluate the translational applications for this knowledge to date. Novel therapeutic strategies have been developed and are under investigation to selectively modulate miRNAs; such work would potentially enable personalised tumour therapy. Conclusions: MiRNAs appear to be important modulators of urologic cancer. Their expression is frequently altered in these tumours, and many are functionally implicated in their pathogenesis. They require evaluation to determine the translational role and therapeutic potential for this knowledge. Crown Copyright (C) 2011 Published by Elsevier B. V. on behalf of European Association of Urology. All rights reserved.},
  author       = {Catto, James W. F. and Alcaraz, Antonio and Bjartell, Anders and White, Ralph De Vere and Evans, Christopher P. and Fussel, Susanne and Hamdy, Freddie C. and Kallioniemi, Olli and Mengual, Lourdes and Schlomm, Thorsten and Visakorpi, Tapio},
  issn         = {1873-7560},
  keyword      = {MicroRNA,Gene regulation,Prostate,Bladder,Kidney,Cancer},
  language     = {eng},
  number       = {5},
  pages        = {671--681},
  publisher    = {Elsevier},
  series       = {European Urology},
  title        = {MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review},
  url          = {http://dx.doi.org/10.1016/j.eururo.2011.01.044},
  volume       = {59},
  year         = {2011},
}